Severity of illness models for respiratory syncytial virus-associated hospitalization

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 4 I, 1999, Pages 1234-1240

  Moler, Frank W ^a,b   Ohmit, Suzanne E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA ANALYSIS; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; LUNG INFECTION; MODEL; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

EID: 0032938376     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.4.9807075     Document Type: Article

References (35)

1. Kim, H. W., J. G. Canchola, C. D. Brant, G. Pyles, R. M. Chanock, K. Jensen, and R. H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
2. Wheeler, J. G., J. Wofford, and R. B. Turner, 1993. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 12:209-213.
3. Moler, F. W., C. M. Steinhart, S. E. Ohmit, and G. L. Stidham for the Pediatric Critical Care Study Group. 1996. Effectiveness of ribavirin in otherwise well infants with RSV-associated respiratory failure. J. Pediatr. 128:422-428.
4. Ohmit, S. E., F. W. Moler, A. S. Monto, and A. S. Khan. 1996. Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection. J. Clin. Epidemiol. 49:963-967.
5. Law, B. J., E. E. Wang, N. MacDonald, and members of the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). 1997. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the Pediatrics Investigators Collaborative Network on Infections in Canada (PICNIC) RSV database. Pediatrics 99(3). URL: http.//www.pediatrics.org/egi/content/full/99/3/e7.
6. American Academy of Pediatrics, Committee on Infectious Disease. 1996, Reassessment of the indications for ribavirin therapy in RSV infections. Pediatrics 97:137-140.
7. The PREVENT Study Group. 1997. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 99:93-99.
8. The Impact-RSV Study Group. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalisation from respiratory syncytial virus infection in high-risk infants. Pediatrics 102: 531-537.
9. American Academy of Pediatrics, Committee on Infectious Disease. 1997. Respiratory syncytial virus immune globulin intravenous: indications for use. Pediatrics 99:645-650.
10. American Academy of Pediatrics, Committee on Infectious Disease. 1998. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 102:1211-1216.
11. Taber, L. H., V. Knight, B. E. Gilbert, H. W. McClung, S. Z. Wilson, H. J. Norton, J. M. Thurson, W. H. Gordon, R. L. Atmar, and W. R. Schlaudt. 1983. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 72:613-618.
12. Hall, C. B., J. T. McBride, E. E. Walsh, D. M. Bell, C. L. Gala, S. Hildreth, L. G. Ten Eyck, and W. J. Hall. 1983. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double blind study. N. Engl. J. Med. 308:1443-1447.
13. Rodriguez, W. J., H. W. Kim, C. D. Brant, P. J. Fink, P. R. Getson, J. Arrobio, T. M. Murphy, V. McCarthy, and R. H. Parrott. 1987. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus infection. Pediatr. Infect. Dis. 6:159-163.
14. Barry, W., F. Cockburn, R. Cornall, J. F. Price, G. Sutherland, and A. Vardag. 1986. Ribavirin aerosol for acute bronchiolitis. Arch. Dis. Child. 61:593-597.
15. Hall, C. B., J. T. McBride, C. L. Gala, S. W. Hildreth, and K. C. Schnabel. 1985. Ribavirin treatment of respiratory syncytial infection in infants with underlying cardiopulmonary disease. J.A.M.A. 254:3047-3051.
16. Groothuis, J. R., K. A. Woodin, R. Katz, A. D. Robertson, J. T. McBride, C. B. Hall, B. C. McWilliams, and B. A. Lauer. 1990. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J. Pediatr. 117:792-798.
17. Smith, D. W., L. R. Frankel, L. H. Mathers, A. T. Tang, R. L. Adriagno, and C. G. Prober. 1991. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N. Engl. J. Med. 325:24-29.
18. Meert, K. L., A. P. Sarniak, M. J. Gelmini, and M. W. Lieh-Lai. 1994. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit. Care Med. 22:566-572.
19. Simocs, E. A. F., J. R. Groothuis, D. A. Tristram, et al. 1996. Respiratory syncytial virus immunoglobulin as prophylaxis against respiratory syncytial virus in children with congenital heart disease (abstract). Pediatr. Res. 39:113A.
20. Rodriguez, W. J., W. C. Gruber, R. C. Welliver, J. R. Groothuis, E. A. Simocs, H. C. Meissner, V. G. Hemming, C. B. Hall, M. L. Lepow, A. J. Rosas, C. Robertsen, and A. A. Kramer, for the Respiratory Syncytial Virus Immune Globulin Study Group. 1997. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infection. Pediatrics 99:454-461.
21. MacDonald, N. E., C. B. Hall, S. C. Suffin, C. Alexson, P. J. Harris, and J. A. Manning. 1982. Respiratory syncytial viral infection in infants with congenital heart disease. N. Engl. J. Med. 307:397-400.
22. Meert, K., S. Heidemann, B. Abella, and A. Sarnaik, 1990. Does prematurity alter the course of respiratory syncytial virus infection? Crit. Care Med. 18:1357-1359.
23. Groothuis, J. R., K. M. Gutierrez, and B. A. Laven, 1988. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 82:199-203.
24. Hall, C. B., K. R. Powell, N. E. MacDonald, C. L. Gala, M. E. Menegus, S. C. Suffin, and H. J. Cohen. 1986. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315:77-81.
25. Hall, C. B., R. G. Douglas, Jr., J. M. Geiman, and M. K. Messner. 1975. Nosocomial respiratory syncytial virus infections. N. Engl. J. Med. 293:1343-1346.
26. Groothuis, J. R., E. A. Simones, M. J. Leven, C. B. Hall, C. E. Long, W. J. Rodriguez, J. Arrobio, H. C. Meissner, D. R. Fulton, R. C. Welliver, D. A. Tristram, G. R. Siber, G. A. Prince, M. V. Raden, V. G. Hemming, and the Respiratory Syncytial Virus Immune Globulin Study Group. 1993. Prophylactic administration of respiratory syncytial immune globulin to high-risk infants and young children. N. Engl. J. Med. 329:1524-1530.
27. Wang, E. E., B. J. Law, D. Stephens, and other members of PICNIC. 1995. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J. Pediatr. 126:212-219.
28. Pollack, M. M., U. E. Ruttimann, and P. R. Getson. 1988. Pediatric risk of mortality (PRISM) score. Crit. Care Med. 16:110-1116.
29. Knaus, W. A., D. P. Wagner, E. A. Draper, J. E. Zimmerman, M. Bergner, P. G. Bastos, C. A. Sirio, D. J. Murphy, T. Lotring, A. Damiano, and F. E. Harrel. 1991. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619-1636.
30. Ruttimann, U. E. 1994. Statistical approaches to development and validation of predictive instruments. Crit. Care Clin. 10:19-35.
31. Lemeshow, S., and J. R. Le Gall. 1994. Modeling the severity of illness of ICU patients: a systems update. J.A.M.A. 272:1049-1055.
32. Laupacis, A., N. Sekar, and I. G. Stiell. 1997. Clinical prediction rules: a review and suggested modifications of methodologic standards. J.A.M.A. 277:488-494.
33. SAS Institute Inc. 1995. Logistic regression examples using the SAS system, Version 6. 1st ed. SAS Institute Inc., Cary, NC.
34. Hur, K., C. A. Oprian, W. G. Henderson, B. Thakkar, and S. Urbanski. 1996. A SAS macro for validating a logistic model with split sample and bootstrap methods: proceedings of the Twenty-First Annual SAS Users Group International Conference, SAS Institute Inc., Cary NC. 953-956.
35. Langley, J. M., E. E. Wang, B. J. Law, D. Stevens, F. D. Boucher, S. Dobson, J. McDonald, and N. E. MacDonald. 1997. Economic evaluation of respiratory syncytial virus infection in Canadian children. J. Pediatr. 131:113-137.